Cargando…
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators
BACKGROUND: Chemotherapy-induced neuropathic pain (CIPN) describes a pathological pain state that occurs dose-dependently as a side effect and can limit or even impede an effective cancer therapy. Unfortunately, current treatment possibilities for CIPN are remarkably confined and mostly inadequate a...
Autores principales: | Wedel, Saskia, Hahnefeld, Lisa, Schreiber, Yannick, Namendorf, Christian, Heymann, Tim, Uhr, Manfred, Schmidt, Mathias V., de Bruin, Natasja, Hausch, Felix, Thomas, Dominique, Geisslinger, Gerd, Sisignano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290418/ https://www.ncbi.nlm.nih.gov/pubmed/37355700 http://dx.doi.org/10.1186/s12974-023-02835-5 |
Ejemplares similares
-
SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain
por: Wedel, Saskia, et al.
Publicado: (2022) -
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury
por: Wedel, Saskia, et al.
Publicado: (2022) -
Sex differences in the effect of the FKBP5 inhibitor SAFit2 on anxiety and stress-induced reinstatement following cocaine self-administration
por: Connelly, Krista L., et al.
Publicado: (2020) -
In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse
por: Homann, Julia, et al.
Publicado: (2015) -
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022)